Latest Breaking News On - Proton therapy technology development - Page 1 : comparemela.com

Concurrent Durvalumab/CRT Does Not Confer Significant Survival Advantage in Unresectable Stage III NSCLC

Durvalumab/chemoradiation did not significantly improve survival vs chemoradiation alone in patients with unresectable non–small cell lung cancer.

United statesCzech republicUniversity of pennsylvaniaJeffreyd bradleyHospital of the university pennsylvaniaEuropean lung cancer congressProton therapy technology developmentWorld health organizationLung cancerProton therapyTechnology developmentEastern europeLung cancer congressAdding durvalumab to concurrent chemoradiationPatients with unresectable stage iii non small cell lung cancer

PACIFIC-2 Trial: Imfinzi, Chemoradiotherapy Tested on Stage III Lung Cancer

PACIFIC-2 Trial: Imfinzi, Chemoradiotherapy Tested on Stage III Lung Cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomJeffreyd bradleyDaiichi sankyoSusan galbraithLung ambition allianceProton therapy technology developmentVice chairProton therapyTechnology developmentPenn medicineExecutive vice presidentRare diseases

AstraZeneca : Update on PACIFIC-2 Phase III trial of Imfinzi concurrently administered with platinum-based chemoradiotherapy in unresectable, Stage III non-small cell lung cancer -November 14, 2023 at 02:08 am EST

The PACIFIC-2 Phase III trial for Imfinzi concurrently administered with chemoradiotherapy did not achieve statistical significance for the primary endpoint of progression-free.

United statesUnited kingdomJeffreyd bradleySusan galbraithDaiichi sankyoProton therapy technology developmentLung ambition allianceVice chairProton therapyTechnology developmentPenn medicineExecutive vice presidentRare diseases

AstraZeneca (AZN) reports PACIFIC-2 Phase III trial for Imfinzi did not meet endpoints

AstraZeneca (AZN) reports PACIFIC-2 Phase III trial for Imfinzi did not meet endpoints
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSusan galbraithJeffreyd bradleyProton therapy technology developmentVice chairProton therapyTechnology developmentPenn medicineExecutive vice president